PHOSPHATIDYLGLYCEROL DEPENDENT PROTEIN TRANSLOCATION ACROSS THE ESCHERICHIA-COLI INNER MEMBRANE IS INHIBITED BY THE ANTICANCER DRUG DOXORUBICIN - EVIDENCE FOR AN ELECTROSTATIC INTERACTION BETWEEN THE SIGNAL SEQUENCE AND PHOSPHATIDYLGLYCEROL

Citation
Da. Phoenix et al., PHOSPHATIDYLGLYCEROL DEPENDENT PROTEIN TRANSLOCATION ACROSS THE ESCHERICHIA-COLI INNER MEMBRANE IS INHIBITED BY THE ANTICANCER DRUG DOXORUBICIN - EVIDENCE FOR AN ELECTROSTATIC INTERACTION BETWEEN THE SIGNAL SEQUENCE AND PHOSPHATIDYLGLYCEROL, FEBS letters, 324(1), 1993, pp. 113-116
Citations number
22
Categorie Soggetti
Biophysics,Biology
Journal title
ISSN journal
00145793
Volume
324
Issue
1
Year of publication
1993
Pages
113 - 116
Database
ISI
SICI code
0014-5793(1993)324:1<113:PDPTAT>2.0.ZU;2-D
Abstract
OmpF-Lpp, a model secretory protein, requires both a positively charge d signal sequence and phosphatidylglycerol (PG) for efficient transloc ation across the E coli inner membrane. Modification of the signal seq uence can, however, remove both these prerequisites for translocation providing OmpF-Lpp mutants which undergo either PG and charge dependen t or PG and charge independent translocation. Here we show that positi vely charged membrane interactive compounds (polylysine & doxorubicin) are able to inhibit PG dependent translocation of the OmpF-Lpp signal sequence mutants but not PG independent translocation. Doxorubicin is also shown to bind more efficiently to liposomes containing increased levels of anionic lipid indicating that in these assays it may be inh ibiting translocation by preventing electrostatic interaction between the anionic lipid head group and the positively charged signal sequenc es.